Araştırma Makalesi

A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study

Cilt: 12 Sayı: 6 30 Kasım 2022
PDF İndir
EN TR

A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study

Öz

Aim: Diagnostic biomarkers are needed for pediatric acute appendicitis (AA). We hypothesized that presepsin (soluble CD14 subtype), a biomarker for sepsis, can also be used in pediatric AA and aimed to investigate its diagnostic value in those patients. Materials and Methods: This prospective case-control study was conducted on children admitted to the Pediatric Emergency Department with suspected acute appendicitis. Serum levels of interleukin-6, and presepsin were statistically analyzed for their diagnostic values. Results: No remarkable demographic differences were present between the 41 cases and 47 controls. Clinical and routine laboratory findings were significantly positive for acute appendicitis in the cases compared to controls. ROC analysis indicated an AUC for presepsin as 0.999 (CI 95%: 0.890-0.993) and for interleukin-6 as 0.963 (CI 95%:0.949-1.000). The best cut-off point value for presepsin was at 739 pg/ml, corresponding to a sensitivity of 97.56% and a specificity of 100%. The best cut-off point value for interleukin-6 was at 19 pg/ml, corresponding to a sensitivity of 97.56% and a specificity of 90.32%. Conclusions: Our study results indicate that presepsin can be considered a biomarker for diagnosing appendicitis in pediatric cases. Future studies might better include the combination with other biomarkers in pediatric cases.

Anahtar Kelimeler

Kaynakça

  1. Podany AB. Acute Appendicitis in Pediatric Patients: An Updated Narrative Review. J Clin Gastroenterol Treat 2017; 3: 042. Gill PJ, Anwar MR, Thavam T, et al. Identifying Conditions with High Prevalence, Cost, and Variation in Cost in US Children’s Hospitals. JAMA Netw Open 2021; 4: e2117816

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

30 Kasım 2022

Gönderilme Tarihi

4 Eylül 2022

Kabul Tarihi

20 Eylül 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 12 Sayı: 6

Kaynak Göster

APA
Taşar, S., Fidancı, İ., Bulut, İ., Cesur, Ö., Avcı, N., Çalık, G., Şeneş, M., & Taşar, M. (2022). A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study. Journal of Contemporary Medicine, 12(6), 859-865. https://doi.org/10.16899/jcm.1170883
AMA
1.Taşar S, Fidancı İ, Bulut İ, vd. A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study. Journal of Contemporary Medicine. 2022;12(6):859-865. doi:10.16899/jcm.1170883
Chicago
Taşar, Serçin, İlknur Fidancı, İsmail Bulut, vd. 2022. “A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study”. Journal of Contemporary Medicine 12 (6): 859-65. https://doi.org/10.16899/jcm.1170883.
EndNote
Taşar S, Fidancı İ, Bulut İ, Cesur Ö, Avcı N, Çalık G, Şeneş M, Taşar M (01 Kasım 2022) A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study. Journal of Contemporary Medicine 12 6 859–865.
IEEE
[1]S. Taşar vd., “A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study”, Journal of Contemporary Medicine, c. 12, sy 6, ss. 859–865, Kas. 2022, doi: 10.16899/jcm.1170883.
ISNAD
Taşar, Serçin - Fidancı, İlknur - Bulut, İsmail - Cesur, Özkan - Avcı, Nihal - Çalık, Gizem - Şeneş, Mehmet - Taşar, Medine. “A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study”. Journal of Contemporary Medicine 12/6 (01 Kasım 2022): 859-865. https://doi.org/10.16899/jcm.1170883.
JAMA
1.Taşar S, Fidancı İ, Bulut İ, Cesur Ö, Avcı N, Çalık G, Şeneş M, Taşar M. A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study. Journal of Contemporary Medicine. 2022;12:859–865.
MLA
Taşar, Serçin, vd. “A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study”. Journal of Contemporary Medicine, c. 12, sy 6, Kasım 2022, ss. 859-65, doi:10.16899/jcm.1170883.
Vancouver
1.Serçin Taşar, İlknur Fidancı, İsmail Bulut, Özkan Cesur, Nihal Avcı, Gizem Çalık, Mehmet Şeneş, Medine Taşar. A Pilot Study on the Performance of Presepsin in Acute Appendicitis: A Prospective Case-Control Study. Journal of Contemporary Medicine. 01 Kasım 2022;12(6):859-65. doi:10.16899/jcm.1170883